HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway.

Abstract
Cyclooxygenase-2 (COX-2) is an important inducible enzyme in inflammation and is overexpressed in a variety of cancers. Evidence is rapidly accumulating that chronic inflammation may contribute to carcinogenesis through increase of cell proliferation, angiogenesis, and metastasis in a number of neoplasms, including colorectal carcinoma. In the present study, we investigated some mechanistic aspects of DFX-induced hypoxia-driven COX-2 expression. Desferrioxamine (DFX), an iron chelator, is known to upregulate inflammatory mediators. DFX induced the expression of COX-2 and accumulation of HIF-1alpha protein in dose-dependent manners, but hypoxia mimetic agent cobalt chloride (CoCl2) induced accumulation of HIF-1alpha protein but not increase of COX-2 expression. DFX-induced increase of COX-2 expression and HIF-1alpha protein level was attenuated by addition of ferric citrate. This result suggested that the iron chelating function of DFX was important to induce the increase of COX-2 and HIF-1alpha protein. PD98059 significantly inhibited the induction of COX-2 protein and accumulation of HIF-1alpha, suggesting that DFX-induced increase of HIF-1alpha and COX-2 protein was mediated, at least in part, through the ERK signaling pathway. In addition, pretreatment with NS-398 to inhibit COX-2 activity also effectively suppressed DFX-induced HIF-1alpha accumulation in human colon cancer cells, providing the evidence that COX-2 plays as a regulator of HIF-1alpha accumulation in DFX-treated colon cancer cells. Together, our findings suggest that iron metabolism may regulate stabilization of HIF-1alpha protein by modulating cyclooxygenase-2 signaling pathway.
AuthorsKyung Jin Woo, Tae-Jin Lee, Jong-Wook Park, Taeg Kyu Kwon
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 343 Issue 1 Pg. 8-14 (Apr 28 2006) ISSN: 0006-291X [Print] United States
PMID16527254 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclooxygenase 2 Inhibitors
  • Ferric Compounds
  • Flavonoids
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Iron Chelating Agents
  • Tumor Suppressor Protein p53
  • ferric citrate
  • Cyclooxygenase 2
  • Mitogen-Activated Protein Kinases
  • Deferoxamine
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Topics
  • Colonic Neoplasms (metabolism)
  • Cyclooxygenase 2 (drug effects, metabolism)
  • Cyclooxygenase 2 Inhibitors (pharmacology)
  • Deferoxamine (pharmacology)
  • Ferric Compounds (pharmacology)
  • Flavonoids (pharmacology)
  • Humans
  • Hypoxia (chemically induced, metabolism)
  • Hypoxia-Inducible Factor 1, alpha Subunit (antagonists & inhibitors, metabolism)
  • Iron Chelating Agents (pharmacology)
  • Mitogen-Activated Protein Kinases (antagonists & inhibitors, metabolism)
  • Signal Transduction
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: